Kyntra Bio (KYNB) Finished Goods (2018 - 2024)
Kyntra Bio (KYNB) posted Finished Goods of $5.2 million for Q3 2024, up 6.69% sequentially from $4.9 million in Q2 2024, and up 13.08% YoY from $4.6 million in Q4 2023.
Kyntra Bio (KYNB) Finished Goods (2018 - 2024) Analysis & Trends
Kyntra Bio has reported Finished Goods for 7 years, with the latest figure at $5.2 million in Q3 2024.
- Quarterly Finished Goods rose 13.08% year-over-year to $5.2 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $5.2 million (up 13.08% YoY) and the FY2023 annual result came in at $5.6 million, up 74.66% from the prior year.
- Finished Goods grew to $5.2 million in Q3 2024 per KYNB's latest filing, from $4.9 million in the prior quarter.
- Over five years, Finished Goods peaked at $8.2 million in Q4 2021 and troughed at $3.2 million in Q4 2022.
- A 5-year average of $5.6 million and a median of $5.2 million in 2022 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2020 and 2022: Finished Goods surged 2879.87% in 2020, then slumped 60.85% in 2022.
- Over 5 years, Finished Goods stood at $6.1 million in 2020, then surged by 33.37% to $8.2 million in 2021, then tumbled by 60.85% to $3.2 million in 2022, then soared by 74.66% to $5.6 million in 2023, then fell by 6.48% to $5.2 million in 2024.
- According to Business Quant data, Finished Goods over the past three periods registered $5.2 million, $4.9 million, and $5.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - |
| 10 | Kyntra Bio | 29.71 Mn | 29.71 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 5.21 Mn |
| Jun 30, 2024 | 4.89 Mn |
| Mar 31, 2024 | 5.66 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 4.61 Mn |
| Jun 30, 2023 | 4.75 Mn |
| Mar 31, 2023 | 3.96 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 3.51 Mn |
| Jun 30, 2022 | 5.19 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 8.15 Mn |
| Sep 30, 2021 | 7.83 Mn |
| Jun 30, 2021 | 7.80 Mn |
| Mar 31, 2021 | 7.80 Mn |
| Dec 31, 2020 | 6.11 Mn |
| Sep 30, 2020 | 5.03 Mn |
| Jun 30, 2020 | 4.44 Mn |
| Mar 31, 2020 | 5.00 Mn |
| Dec 31, 2019 | 4.30 Mn |